Latest Health News

Dusk Group Limited reported a robust 8.7% sales increase in FY25, driven by innovative product collaborations and a surge in online sales. The company is accelerating its growth strategy with a fresh store concept and a major refresh of its core product range.

Newmont Corporation has announced a quarterly dividend of USD 0.25 per security, payable in December 2025, offering investors flexible currency payment options.

Tourism Holdings Limited (thl) reported a challenging FY25 with a significant profit decline but is confident in a growth rebound supported by international tourism recovery and strategic initiatives.

Pro-Pac Packaging Limited has appointed voluntary administrators as it confronts financial distress, initiating a process to stabilise operations and explore strategic options including sale or recapitalisation.

Icetana Limited reports a strategic pivot to a SaaS-driven revenue model with recurring income now dominating its sales, despite a 49% drop in total revenue for FY25. A landmark partnership with SoftBank Robotics aims to fuel growth in Japan and beyond.

LGI Limited has secured $56.2 million through a fully underwritten institutional placement and a Share Purchase Plan to fast-track its renewable energy projects and expand operating capacity beyond 80 MW. The capital raise underpins the company’s strategic growth in landfill biogas recovery and battery storage solutions amid rising energy market volatility.

BCI Minerals reports significant progress at its Mardie Salt Operation and Potash Project with near-complete pond inundation and major construction milestones achieved in the September 2025 quarter.

Salter Brothers Emerging Companies Limited has announced a further 12-month extension of its on-market share buy-back program, allowing the company to repurchase up to 8.45 million shares to maintain capital management flexibility and enhance shareholder value.

Black Canyon Limited reported a robust cash position of A$11.6 million at the end of September 2025, supported by a strong equity raise that extends its funding runway to nearly three years.

Avecho Biotechnology has raised $2.5 million from institutional investors to fast-track manufacturing and regulatory preparations for its CBD TPM capsule amid ongoing Phase III trials.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.